Lessons from the Stroke Prevention in Atrial Fibrillation Trials

Keyphrases

• Atrial Fibrillation 100%
• Aspirin 100%
• Stroke Prevention in Atrial Fibrillation 100%
• Warfarin 80%
• Anticoagulation 60%
• Low Risk 40%
• Antithrombotic Therapy 40%
• Cardioembolic Stroke 40%
• Preventing Stroke 20%
• Patient Preference 20%
• High Risk 20%
• Bleeding 20%
• Clinical High Risk 20%
• Stroke Patients 20%
• Multicenter Trial 20%
• Risk Estimation 20%
• Thromboprophylaxis 20%
• Patient Access 20%
• Elderly Patients 20%
• Young Patients 20%
• Neurological Disorders 20%
• Stroke Prevention 20%
• Aspirin Therapy 20%
• Moderate Risk 20%
• Stroke Rate 20%
• Transesophageal Echocardiography 20%
• Thrombus Formation 20%
• Unique Perspectives 20%
• Antithrombotic Agents 20%
• Left Atrial Thrombus 20%
• Paroxysmal Atrial Fibrillation 20%
• Anticoagulation Monitoring 20%
• Stroke Assessment 20%
• Atrial Thrombus 20%
• Risk Stratification System 20%

Medicine and Dentistry

• Apoplexy 100%
• Atrial Fibrillation 100%
• Acetylsalicylic Acid 35%
• Anticoagulation 23%
• Warfarin 23%
• Antithrombotic Therapy 11%
• Thrombus 5%
• Risk Stratification 5%
• Nervous System Disorder 5%
• Antithrombotic 5%
• Elderly Patient 5%
• Cardioembolic Stroke 5%
• Patient Preference 5%
• Blood Clotting 5%
• Paroxysmal Atrial Fibrillation 5%
• Heart Atrium Thrombosis 5%
• Antithrombotic Agent 5%